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Abstract
Background
Since cholera appeared in Africa during the 1970s, cases have been reported on the conti-
nent every year. In Sub-Saharan Africa, cholera outbreaks primarily cluster at certain hot-
spots including the African Great Lakes Region and West Africa.
Methodology/Principal Findings
In this study, we applied MLVA (Multi-Locus Variable Number Tandem Repeat Analysis)
typing of 337 Vibrio cholerae isolates from recent cholera epidemics in the Democratic Re-
public of the Congo (DRC), Zambia, Guinea and Togo. We aimed to assess the relationship
between outbreaks. Applying this method, we identified 89 unique MLVA haplotypes across
our isolate collection. MLVA typing revealed the short-term divergence and microevolution
of these Vibrio cholerae populations to provide insight into the dynamics of cholera out-
breaks in each country. Our analyses also revealed strong geographical clustering. Isolates
from the African Great Lakes Region (DRC and Zambia) formed a closely related group,
while West African isolates (Togo and Guinea) constituted a separate cluster. At a country-
level scale our analyses revealed several distinct MLVA groups, most notably DRC 2011/
2012, DRC 2009, Zambia 2012 and Guinea 2012. We also found that certain MLVA types
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Conclusions/Significance
To effectively combat the disease, it is critical to understand the mechanisms of cholera
emergence and diffusion in a region-specific manner. Overall, these findings demonstrate
the relationship between distinct epidemics in West Africa and the African Great Lakes Re-
gion. This study also highlights the importance of monitoring and analyzing Vibrio cholerae
isolates.
Author Summary
Cholera is caused by the toxigenic bacterium Vibrio cholerae. Since cholera was imported
into the West African country of Guinea in 1970, cases have been reported on the conti-
nent every year. In Sub-Saharan Africa, cholera occurs in a heterogeneous manner; out-
breaks primarily cluster at certain hotspots including the African Great Lakes Region and
West Africa. To gain further insight into the mechanisms by which cholera outbreaks
emerge and diffuse, we performed genetic analyses of 337 Vibrio cholera isolates from the
Democratic Republic of the Congo (DRC), Zambia, Guinea and Togo. Isolates from both
patients and environmental samples were examined. Our findings demonstrate the rela-
tionship between distinct epidemics in West Africa and the African Great Lakes Region.
For example, certain strains in the DRC have circulated in the region over a period of sev-
eral years, occasionally giving rise to expansive epidemics. We also found that the six envi-
ronmental isolates in our panel were unrelated to the epidemic isolates. Such insight into
the country- and region-specific dynamics of the disease is critical to implement optimized
public health strategies to control and prevent cholera epidemics. This study also high-
lights the importance of analyzing Vibrio cholerae isolates to complement epidemiological
studies.
Introduction
Since 1817, seven cholera pandemics have plagued humans worldwide [1]. During the current
pandemic, the disease first appeared on the African continent when Vibrio cholerae was im-
ported by migrants traveling to the Guinean capital of Conakry in 1970 [1]. Following this im-
portation of the bacterium, cholera cases have been reported every year in Africa, and many
regions in Sub-Saharan Africa have been deemed cholera endemic [2].
Although Africa currently has the highest incidence of cholera globally, the disease affects
the continent in a heterogeneous manner. African cholera outbreaks primarily cluster at cer-
tain hotspots including (1) the African Great Lakes Region and (2) West Africa, stretching
from Cameroon and the Lake Chad region along the coast to Guinea [3–6]. Cholera outbreaks
commencing in the African Great Lakes Region have been found to spread to neighboring
countries, such as Sudan in 2006 and Kenya in 2009 [5]. Likewise, epidemics have progressively
moved along the West African coast, as observed in 2003–2007 when outbreaks spread from
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Liberia and Sierra Leone to Guinea [6]. Indeed, cholera appears to spread in a highly dynamic
manner that poses a significant public health threat at a regional level across Africa.
To design effective public health strategies to combat the disease, it is critical to understand
the mechanisms of cholera emergence and diffusion in a region-specific manner. Epidemiolog-
ical analysis of outbreaks is critical to identify hotspots and patterns of disease spread. Howev-
er, molecular biological methods can provide further insight into the relationship between
pathogenic strains and epidemic populations [7]. Indeed, isolate typing is useful to differentiate
between different isolates, identify clusters, establish phylogeny, and track bacterial transmis-
sion. Lam et al. [8] have recently shown that MLVA (Multi-Locus VNTR (Variable Number
Tandem Repeat) Analysis) represents a highly discriminatory technique to distinguish between
closely related seventh pandemic isolates. They have also emphasized that the method is best
applied for outbreak investigations or to identify the source of an outbreak. Our research group
has recently demonstrated that MLVA-based analysis of clinical V. cholerae isolates combined
with an epidemiological assessment was instrumental in deciphering the origin of the 2012
Guinean epidemic [9].
In the current study, we applied MLVA-based typing of 337 V. cholerae isolates from
recent cholera epidemics in Sub-Saharan Africa to assess the relationship between outbreaks.
We identified 89 unique MLVA haplotypes across our isolate collection. When coupled with
corresponding epidemiological data, we revealed the short-term divergence and microevolu-
tion of these V. cholerae populations to provide insight into the dynamics of cholera outbreaks
and the relationship between distinct epidemics in West Africa and the African Great Lakes
Region.
Materials and Methods
V. cholerae isolates
Overall, we analyzed 337 V. cholerae isolates derived from epidemics in the Democratic Repub-
lic of the Congo (DRC), Guinea, Togo and Zambia. Our panel included six isolates from envi-
ronmental samples and 331 clinical samples. A total of 237 V. cholerae isolates from epidemics
in the DRC occurring in 2008 (3 isolates), 2009 (108 isolates), 2011 (60 isolates), 2012 (44 iso-
lates) and 2013 (22 isolates) were provided by the INRB (French acronym for the National In-
stitute of Biomedical Research), Kinshasa, DRC. Of the 60 DRC isolates from 2011, two were
isolated from environmental water samples collected from Lake Tanganyika by staff at the
Centre de recherche en Hydrobiologie (in Uvira, RDC) and analyzed at the Hôpital Générale
de Référence in Uvira by Hilde de Boeck. The Guinean reference laboratory of the Public
Health National Institute (INSP—Institut National de Santé Publique), with support from the
AFRICHOL Consortium (http://www.africhol.org/), provided 36 V. cholerae isolates collected
throughout Guinea during the 2012 epidemic as previously described [9]. The National Insti-
tute of Hygiene in Lomé, Togo provided 35 V. cholerae isolates from Togo, which corre-
sponded to epidemics in 2010 (13 isolates), 2011 (10 isolates) and 2012 (12 isolates provided by
the bacteriology laboratory of the National Institute of Hygiene in Togo via the project AFRI-
CHOL). A total of 27 V. cholerae clinical isolates from the 2012 Zambian epidemic were ana-
lyzed; the isolates were collected by the staff at the Cholera Treatment Center at the Mpulungu
Health Centre during the CHOLTIC project together with the Institute of Tropical Medicine
in Antwerp, Belgium. Two environmental isolates were also collected during the CHOLTIC
project in association with the Department of Fisheries, Lake Tanganyika Research Unit. The
Mpulungu Health Centre performed the initial characterization of the V. cholerae environmen-
tal samples.
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Ethics statement
Regarding the isolates from Zambia, suspected cholera cases were routinely cultured to test for
the presence of V. cholerae. The study, including a waiver of written consent, was approved by
the University of Zambia Biomedical Research Ethics Committee, the Institute of Tropical
Medicine institutional review board, and the ethical committee of the University of Antwerp,
Belgium (study registration number B300201317249). Patients, children’s parents and/or legal
guardians were informed and approved via oral consent before enrollment into the study. Oral
consent was registered by the ward nurse, and participant samples received a study ID number
to anonymize the data.
Concerning the Guinean isolates, the sampling of suspected cholera cases for culture confir-
mation of V. cholerae is included among the routine procedures in accordance with the policies
of the Ministry of Health Guinean. The Ministry of Public Health and Public Hygiene, Conakry
(Ministre de la Santé Publique et de l’Hygiène Publique) approved the use of these V. cholerae
isolates for research and publication purposes.
In Togo, to confirm suspected cholera cases, patient samples are routinely cultured to test
for the presence of V. cholerae. The directorate of the National Institute of Hygiene, Lomé,
Togo (the laboratory director and the head of the bacteriology department) approved the study
of these isolates for research purposes, including the comparison of these Togolese isolates
with other African V. cholerae samples.
In the Democratic Republic of the Congo, samples from suspected cholera cases are routine-
ly collected and analyzed for the presence of V. cholerae in the framework of the epidemiologi-
cal surveillance program of the Ministry of Health. The ethics committee at the University of
Kinshasa approved the analysis of these isolates for research purposes.
All data analyzed in the study were anonymized.
V. cholerae culture and DNA extraction
The isolates were subcultured and inoculated into Vibrio cholerae Enrichment Broth vials (Bio-
Rad). The Bio-Rad vials were subsequently expedited (2–3 days) at ambient temperature to
L'Hôpital d'Instruction des Armées Laveran in Marseille, France. In Marseille, the strains were
recultivated on non-selective trypticase soy agar medium (Difco Laboratories/BD) for 24 hours
at 37°C. Suspected V. cholerae colonies were identified via Gram-staining, oxidase reaction and
agglutination assessment with V. cholerae O1 polyvalent antisera (Bio-Rad).
For DNA extraction, an aliquot of cultured cells (approximately 50 colonies) was suspended
in 500 μL NucliSENS easyMAG lysis buffer (bioMérieux, Marcy l'Etoile, France). Total nucleic
acid was extracted from V. cholerae cultures using a NucliSENS easyMAG platform (bioMér-
ieux) according to the manufacturer’s instructions. Nucleic acid concentration and 260/280
ratio were measured using a NanoDrop 3300 fluorospectrometer (Thermo Scientific, Villebon
sur Yvette, France). The supernatants (100 μL) were stored at -20°C for downstream
applications.
MLVA-based typing
Genotyping of the V. cholerae isolates was performed via MLVA of six VNTRs, including five
previously described assays and a novel VNTR assay, VCMS12, specifically designed for this
study to improve the discriminative power of the analysis (Table 1) [9–11]. The VCMS12 assay
was designed based on the reference strain El Tor N16961 (GenBank accession numbers
AE003852.1 and AE003853.1) using Perfect Microsatellite Repeat Finder (currently unavail-
able). VCMS12 is located within the cholera toxin A subunit promoter region at position
1568189 on chromosome 1 of El Tor N16961. This polymorphic tandem heptanucleotide
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repeat region has been previously identified by Naha et al [12]. Specific primer pairs were sub-
sequently designed using Primer3 (http://simgene.com/Primer3). The fluorescent-labeled
primers (Table 1) were purchased from Applied Biosystems.
Each VNTR locus was amplified separately. DNA amplification was carried out by prepar-
ing a PCR mix containing the following components: 0.375 μL of each primer (20 μM), 1 X
LightCycler 480 Probes Master (Roche Diagnostics) and approximately 100 ng of template
DNA. The PCR mix was brought to a total volume of 30 μL with H2O. PCR was performed
using a LightCycler 480 System (Roche Diagnostics). All PCRs were performed using the ther-
mal cycling conditions as follows: 95°C for 5 min; followed by 30 cycles of 95°C for 30 sec,
58°C for 30 sec and 72°C for 45 sec; 72°C for 5 min.
Aliquots of the PCR products were first diluted 1:30 in sterile water. Next, 1 μL of the diluted
PCR reaction was aliquoted into a solution containing 25 μL Hi-Di Formamide 3500 Dx Series
(Applied Biosystems) and 0.5 μL GeneScan 500 LIZ Size Standard (Applied Biosystems). The
fluorescent end-labeled PCR amplicons were separated via capillary electrophoresis using an
ABI PRISM 310 Genetic Analyzer (Applied Biosystems) with POP-7 Polymer (Applied Biosys-
tems). Finally, amplicon size was determined using GeneMapper v.3.0 software (Applied
Biosystems).
Data analysis
The MLVA results were exported to Microsoft Excel 2008 v. 12.2.0. Allele numbers were de-
rived directly from the fragment sizes, and MLVA types were determined from the combined
profile of alleles (i.e., each unique combination of six allele numbers was assigned a novel
MLVA type number). The absence of allele at a given locus (i.e., no amplification, despite re-
peated attempts) was assigned “999” for further analyses. No amplification was observed for 22
of the 2022 examined alleles. To perform the Minimum Spanning Tree (MST) analysis, the iso-
lates were further assigned into 10 epidemic populations as follows: DRC 2008, DRC 2009 A
(collected in January-May), DRC 2009 B (collected in July-November), DRC 2011, DRC 2012,
DRC 2013, Guinea 2012, Zambia 2012, Togo 2010, Togo 2011 and Togo 2012. The DRC 2009
epidemic isolates were sub-grouped by time period as two distinct epidemics were observed in
the region during field investigations.
Table 1. Characteristics and primer sequences of the six tested V. cholerae VNTRs.
VNTR Locus name Repeated pattern Chr.1 Position2 Primer sequence (5'!3') Ref.
VC1 AACAGA 1 137106 fw: CGGATACTCAAACGCAGGAT [10,11]
rv: 6FAM-CTTTCGGTCGGTTTCTCTTG
VC4 TGCTGT 2 187759 fw: TGTTTGAGAGCTCGCCTCTT [10,11]
rv: PET-TCATCAAGATGCACGACACA
VC5 GATAATCCA 1 1915539 fw: AGTGGGCACAGAGTGTCAAA [10,11]
rv: VIC-AATTGGCCGCTAACTGAGTG
VC9 GACCCTA 1 467111 fw: CGTTAGCATCGAAACTGCTG [10,11]
rv: NED-AGAAAACAATCGCCTGCTTG
LAV6 ACCAGA 2 303939 fw: NED-GCCTCCTCAGAAGTTGAGAATC [9]
rv: CCGATGAACTCTCTGAACTGG
VCMS12 TTTTGAT 1 1568189 fw: VIC-GAGGTCTAGAATCTGCCCGA Present study
rv: AAGCGCTGTGGGTAGAAGTG
1 Chr.: chromosome.
2 Based on the reference strain El Tor N16961 (GenBank accession numbers: AE003852.1 and AE003853.1).
doi:10.1371/journal.pntd.0003817.t001
Link between African Cholera Epidemics Shown via MLVA of V. cholerae
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003817 June 25, 2015 5 / 15
Cartography
The maps were generated using QGIS version 2.4.0-Chugiak with shapefiles obtained from
DIVA-GIS (http://www.diva-gis.org/gdata).
Minimum Spanning Tree
Based on allelic profiles the evolutionary relationship between all 337 isolates was assessed with
the MST algorithm in BioNumerics (Applied Maths, Sint-Martens-Latem, Belgium) using the
default settings according to the manufacturer’s recommendations. The MST was constructed
using a categorical coefficient as previously described [13].
goeBURST analysis
To identify clonal complexes and founder MLVA types among the 331 clinical isolates (i.e., ex-
cluding the six environmental isolates), MLVA-types were compared at each of the six VNTR
loci and genetic relatedness between the strains was assessed using goeBURST version 1.2.1
(http://goeburst.phyloviz.net/) [14]. The goeBURST algorithm identifies mutually exclusive
groups of related MLVA types in a population. The algorithm also predicts the presumed
founder(s) of each clonal complex and any single locus variant (SLV) and double locus variant
(DLV) derivatives. The primary founder of a group is defined as the MLVA type that has the
greatest number of SLVs. goeBURST then constructed a spanning forest in which each MLVA
type is a node and two MLVA types are connected if they are SLVs. An MLVA cluster was de-
fined as a group of isolates that share identical alleles at five of the six loci with at least one
other member of the group. Accordingly, singletons were defined as MLVA types having at
least two allelic mismatches with all other MLVA types. The number of re-samplings for boot-
strapping was set at 1000.
Population genetics calculations
Population genetic analyses were performed on each set of epidemic isolates for which there
were 10 or more isolates per set; therefore, the three DRC 2008 isolates were excluded from the
statistical analyses. Fst (F-statistics; also known as fixation indices) and p-values were calculat-
ed pair-wise for all epidemic populations of the 328 clinical isolates using the Nei (1987) meth-
od implemented in GenoDive 2.0b25 [15] as were the allelic diversity of all clusters and loci.
Field investigations
Several field investigations were conducted in the DRC, Guinea and Togo by members of our
team (Renaud Piarroux, Stanislas Rebaudet, Berthe Miwanda, Didier Bompangue, Aaron
Aruna Abedi, Jean-Jacques Depina and Sandra Moore). Field investigations were performed at
sites affected by cholera, in which the data collected included number of cases/deaths, laborato-
ry results, the locales affected and the spatiotemporal evolution of the epidemics. Further de-
tails of the field investigations are provided in the corresponding studies of the specific
epidemics (concerning the Togo field investigation, please see S1 Text) [9, 16].
In Zambia, strains collected in the context of the national surveillance system and the
CHOLTIC project with the objective of comparing strains collected in the vicinity of Lake Tan-
ganyika (at sites of varying distances from the coast). Strains were collected in Mpulungu,
Northern Province, between the 12th and 24th of August 2012, during an outbreak that oc-
curred at this time. The following data corresponding to the collected strains was also com-
piled: patient name, sex, age, date seen at facility, date of symptom onset, laboratory results (if
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any were performed) and date of patient discharge. No corresponding field investigation was
performed during this outbreak.
Results
Minimum Spanning Tree and goeBURST analyses of 337 V. cholerae
isolates fromWest and Central Africa
A total of 337 V. cholerae isolates from recent cholera epidemics in the DRC, Zambia, Guinea
and Togo were subjected to MLVA. Each country is localized on the map of Africa in Fig 1.
Analysis of the six VNTRs yielded 89 MLVA types. The VNTR loci and epidemic populations
(grouped by country and year of isolation) corresponding to each MLVA type are outlined in
S1 Table.
A MST was constructed using the combined MLVA data to assess the relationships between
the 337 V. cholerae isolates and the epidemic populations. On a continental scale, the MST re-
vealed strong geographical clustering with isolates from the African Great Lakes Region, in-
cluding the DRC and Zambia, clustering together. Furthermore, the isolates collected in the
West African countries of Guinea and Togo formed a separate group (Fig 2). All but seven clin-
ical isolates from the DRC and Zambia 2012 were linked by one- or two-VNTR variations.
Likewise, all clinical isolates from Guinea 2012 and Togo were linked by one- or two-VNTR di-
vergences. At a country-level scale our analyses revealed several distinct clonal groups, most
notably (1) DRC 2011/2012, (2) DRC 2009, (3) Zambia 2012 and (4) Guinea 2012. We used
goeBURST to identify a potential founder MLVA haplotype for each MLVA cluster. Each epi-
demic complex was characterized by a central founder MLVA haplotype and closely related de-
rivative SLV or DLVMLVA haplotypes, which branched from the founder. In contrast, all six
of the typed environmental isolates were found to be singletons, unrelated to the main clinical
epidemic isolate clusters (Fig 2).
Our analysis showed that the DRC 2011 and DRC 2012 isolates grouped together as one dis-
crete complex (Fig 2). During this two-year period in the DRC, cholera was caused by the ex-
tensive expansion and diversification from a single MLVA haplotype. The isolate found at the
beginning of the 2011/2012 epidemic in Kisangani, Orientale Province in March 2011 was hap-
lotype #67, which was designated the founder of the DRC 2011/2012 complex. MLVA type #67
and a SLV of this haplotype were the only types identified during the first week of the outbreak.
This MLVA cluster then diversified in parallel with the spatiotemporal spread of the epidemic
[16], as the most distant MLVA haplotypes within this cluster were identified in distant prov-
inces in 2012. These findings correlate with an epidemiological report of the cholera epidemic
that struck the DRC in 2011. This epidemic aggressively diffused from the onset point in Kisan-
gani, Orientale Province across the country in less than 130 days. Strikingly, outbreaks followed
the Congo River and quickly reached non-endemic zones in the West that had not experienced
an epidemic for approximately 10 years [16]. Kisangani and the Congo River are localized on
the detailed map of the DRC (Fig 1, lower right).
Interestingly, the predicted founder of the 2011/2012 DRC epidemic, persisted in the coun-
try over the course of several years, as haplotype #67 was represented in isolates collected in the
DRC during the 2009, 2011, 2012 and 2013 epidemics. Only one DRC isolate (MLVA type
#129) collected in 2011 did not belong to the major DRC 2011/2012 MLVA cluster. Instead,
haplotype #129 was a SLV of the DRC 2009 haplotype #116 cluster. In stark contrast, the V.
cholerae non-O1 strain isolated at the same period from a water sample in Uvira, South Kivu
was a genetically unrelated singleton (MLVA type #40) (Fig 2). Uvira is located on the northern
shores of Lake Tanganyika as indicated in Fig 1 (lower right panel).
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Fig 1. Map of African countries implicated in study.Upper panel: the four countries from which V. cholerae isolates were collected are indicated in
different colors on the map of Africa (i.e., Guinea, green; Togo, red; Democratic Republic of the Congo (DRC), violet and Zambia: blue). Ghana and Nigeria
are also labeled. Lower panel: detailed maps of Guinea and the DRC are shown. Lower right: DRC; the cities (red squares) and provinces mentioned are
indicated on the map. The Congo River and Lake Tanganyika are also shown (in blue). Lower left: Guinea; the capital, Conakry, and Kaback Island are
indicated along the Atlantic coast.
doi:10.1371/journal.pntd.0003817.g001
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Overall, the panel of DRC 2009 isolates displayed a high level of genetic diversity. In fact,
four DRC 2009 clinical isolates (MLVA types #39, #43, #21 and #108) collected in February
and March 2009 were designated distantly related singletons (Fig 2). The MST was then ana-
lyzed in further detail considering the date of sample isolation. The isolates collected during
the first half of the year were highly diverse (indicated as “DRC 2009 A” in pink; Fig 2). In con-
trast, 63 of 66 isolates (95.5%) collected from July to November of 2009 in Katanga Province
formed a tight clonal complex (indicated as “DRC 2009 B” in red; Fig 2). This bottleneck effect
was concomitant with an epidemic rebound in Katanga Province after a complete lull in chol-
era transmission in May and June 2009. In July 2009, cholera first appeared in Kalemie, a city
located on the shore of Lake Tanganyika, and then spread throughout the rest of the province
(based on field investigations in the DRC; Renaud Piarroux). MLVA types #110 and #116 were
designated potential founders of this DRC 2009 B MLVA complex. Interestingly, MLVA type
#110 was the first isolate collected on February 5, 2009, and isolates harboring this haplotype
were collected up to November 20, 2009. Notably, MLVA type #110 was also found in August
2009 in Uvira, a city located approximately 360 km north of Kalemie on the shore of Lake Tan-
ganyika (all sites are labeled in the lower right panel of Fig 1). Therefore, we hypothesize that
this strain likely persisted in the region following the early-2009 outbreaks and a subsequently
gave rise to the late-2009 DRC epidemic.
Fig 2. Minimum Spanning Tree based on the MLVA types of 337 V. cholerae isolates derived from several recent African epidemics. Each MLVA
type is represented by a node, and the size of the nodes reflects the number of isolates with the indicated MLVA type. The relationships between isolate
MLVA types are indicated by the type of connecting segments and the length of the segment between nodes. The solid lines indicate the most likely SLV, and
the dashed lines represent DLV. The distance between the nodes represents the number of varying VNTRs. The colors reflect the distinct country and period
of isolate origin (grouped by epidemic populations). Pie charts were used to indicate the distribution of strains isolated from different time periods or countries
displaying identical an MLVA type.
doi:10.1371/journal.pntd.0003817.g002
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In Zambia, all clinical isolates from the 2012 epidemic formed a restricted clonal complex,
which derived from the predicted founder MLVA #30. Once more, the two non-O1 environ-
mental isolates collected from the shores of Lake Tanganyika in Mpulungu, Northern Province
were singletons (MLVA haplotype #13) unrelated to the clonal complex (Fig 2).
The Guinea 2012 clinical isolates formed a solid clonal complex, with an MST of closely re-
lated derivative isolates that stemmed from the founder haplotype (MLVA type #47) (Fig 2). In
a previous study, our group has shown that the Guinea 2012 epidemic appears to be due to the
importation of a toxigenic clone from Sierra Leone. Using MLVA typing, we have demonstrat-
ed progressive genetic diversification of the strains from the founder type correlated with spa-
tiotemporal epidemic spread [9]. The founding MLVA type was also the first and only MLVA
type indentified during the onset of the epidemic, on Kaback Island (Fig 1, lower left), Guinea
in February 2012 [9]. In contrast, the two Guinean environmental strains (MLVA types #1 and
#130) isolated from water samples at the site of the initial outbreak (Kaback) were unrelated
singletons (Fig 2).
Our data showed that the Togo isolates represent a diverse set of MLVA haplotypes, as they
were only related to the Guinean isolate MLVA types by a single DLV (Fig 2). Most of the iso-
lates collected in Togo were designated singletons.
Population genetics
To provide statistical power to the observed relationships between 328 clinical isolates, popula-
tion genetic analyses were performed. The six unrelated environmental isolates and the three
isolates from DRC in 2008 were excluded from this analysis. Taking each MLVA VNTR locus
in turn, this analysis revealed that there were 5, 17, 6, 6, 17 and 5 alleles, for the VNTR loci de-
noted VC1, VC4, VC5, VC9, LAV6 and VC12, respectively (Table 2). The discriminatory
power of the six tested VNTRs was calculated via an index of genetic diversity (IOD) analysis
(Nei, 1987) using GenoDive 2.0b25. The IOD and PCR product size range for each VNTR is
outlined in Table 2. Accordingly, the corrected indices of diversity per locus were 0.758, 0.927,
0.54, 0.512, 0.871 and 0.579 for VC1, VC4, VC5, VC9, LAV6 and VCMS12, respectively. The
overall corrected IOD for the six VNTRs combined was 0.698. The two most variable VNTRs
were located on the small chromosome, which correlates with the observations reported by
Lam et al. [8] (Table 2).
The IOD (based on Nei, 1987) per population was calculated to determine the extent of ge-
netic diversity of each designated population. The epidemics with the highest degree of genetic
diversity were DRC 2009 A (IOD = 0.545) and DRC 2013 (IOD = 0.586). In contrast, the
Table 2. Indices of genetic diversity per locus and observed PCR product size range.
Locus Chromosome Num Eff num Pop div IOD Corr IOD PCR product size range (base pairs)
VC1 1 5 1.516 0.357 0.717 0.758 179–203
VC4 2 17 2.302 0.592 0.893 0.927 169–284
VC5 1 6 1.157 0.142 0.5 0.54 160–215
VC9 1 6 1.226 0.193 0.48 0.512 160–202
LAV6 2 17 2.052 0.537 0.838 0.871 0, 209–329
VC12 1 5 1.053 0.053 0.526 0.579 0, 258–286
Overall 9.333 1.551 0.312 0.659 0.698 -
Genetic diversity (Nei, 1987) of 328 V. cholerae isolates, considering six loci, was calculated in GenoDive 2.0b25. Num = number of alleles; Eff
num = effective number of alleles; Pop div = gene diversity within populations; IOD = Index of Diversity; Corr IOD = corrected Index of Diversity.
doi:10.1371/journal.pntd.0003817.t002
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epidemic isolates derived from Togo 2012 (IOD = 0.152) displayed the lowest diversity. Epi-
demics in DRC 2011 (IOD = 0.218), DRC 2012 (IOD = 0.242), Zambia 2012 (IOD = 0.206)
and Guinea 2012 (IOD = 0.222) also showed relatively low gene diversity (Table 3).
Pairwise differentiation analysis was performed to understand the statistical relationship be-
tween the epidemic populations. The Fst values for all pairs of populations were calculated con-
sidering all 328 V. cholerae clinical isolates. All Fst and p-values are outlined in Table 4. The
closest statistically significant relationship was between the epidemics of DRC 2011 and DRC
2012 (Fst = 0.125, p = 0.001), which is coherent with the rapid diversification and expansion of
an epidemic clone [16].
The DRC 2013 epidemic was closest related to the early DRC 2009 isolates (Fst = 0.107,
p = 0.001), which suggests that the 2013 epidemic was likely due to an expansion of strains cir-
culating in the country during pervious epidemics. The pairwise analysis also demonstrated a
statistically signification relationship between the early and late 2009 isolates from the DRC
(2009 A and 2009 B, respectively) (Fst = 0.276, p = 0.001). These observations further support
Table 3. Indices of genetic diversity per population.
Population Number of samples Number of alleles Effective number of alleles Diversity within populations
DRC 2011 58 3.333 1.398 0.218
DRC 2012 44 2.333 1.723 0.242
DRC 2009 A 39 5.5 2.698 0.545
DRC 2009 B 69 3 1.476 0.256
Guinea 2012 34 2.5 1.397 0.222
DRC 2013 22 4.667 2.962 0.586
Togo 2010 13 2 1.582 0.325
Togo 2011 10 2.167 1.764 0.374
Togo 2012 12 2 1.238 0.152
Zambia 2012 27 2 1.313 0.206
Genetic diversity (Nei, 1987) per population of the 328 V. cholerae isolates was calculated in GenoDive 2.0b25.
doi:10.1371/journal.pntd.0003817.t003
Table 4. Pairwise differentiation.
Epidemic
population
DRC
2011
DRC
2012
DRC 2009
A
DRC 2009
B
Guinea
2012
DRC
2013
Togo
2010
Togo
2011
Togo
2012
Zambia
2012
DRC 2011 – 0.125 0.371 0.607 0.743 0.37 0.706 0.692 0.759 0.637
DRC 2012 0.001 – 0.319 0.571 0.732 0.33 0.707 0.69 0.737 0.592
DRC 2009 A 0.001 0.001 – 0.276 0.464 0.107 0.444 0.423 0.53 0.429
DRC 2009 B 0.001 0.001 0.001 – 0.66 0.353 0.655 0.643 0.714 0.661
Guinea 2012 0.001 0.001 0.001 0.001 – 0.516 0.486 0.475 0.693 0.662
DRC 2013 0.001 0.001 0.001 0.001 0.001 – 0.447 0.418 0.551 0.476
Togo 2010 0.001 0.001 0.001 0.001 0.001 0.001 – -0.076 0.525 0.658
Togo 2011 0.001 0.001 0.001 0.001 0.001 0.001 0.829 – 0.461 –.65
Togo 2012 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 – 0.773
Zambia 2012 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 –
The Fst values for all pairs of populations were calculated with GenoDive 2.0b25, considering 328 clinical V. cholerae isolates and six loci. The Fst values
are listed on the top triangle, while the corresponding p-values are listed in the lower triangle.
doi:10.1371/journal.pntd.0003817.t004
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the hypothesis that the late 2009 epidemic came about following a bottleneck of the early 2009
DRC epidemic isolates.
Discussion
Overall, our results provide novel insight into the epidemic phenomena of cholera in West and
Central Africa. At the sub-regional level, MST analysis revealed two distinct African clusters:
(1) the African Great Lakes Region group, comprising DRC and Zambia isolates, and (2) the
West African cluster with isolates from Togo and Guinea. At the country level, the epidemic
V. cholerae populations from DRC 2011/2012, Zambia 2012, Guinea 2012 and late-2009 DRC
were each designated tight complexes. The expansion of the isolate populations coincided with
the progression of each epidemic, as the founder MLVA types corresponded to isolates collect-
ed at outbreak onset and more distantly related derivatives represented isolates found later dur-
ing the epidemic.
Analysis of isolates from the DRC revealed that certain strains appear to remain in circula-
tion in the country over a period of several years and eventually engender explosive outbreaks
with diversification of founding isolates, as observed in 2011. This phenomenon is distinct
from that observed in Togo, where isolates were grouped into a loosely connected quasi-com-
plex without a founder MLVA type. The Togo isolate results rather indicate that when out-
breaks occur, the isolates fail to diversify or diffuse throughout the country. A field assessment
of outbreaks in Togo has revealed that the country is vulnerable to importation of cholera cases
from neighboring countries, although outbreaks are then quickly extinguished (UNICEF field
investigation (Sandra Moore) and personal communication with Dr Adodo Yao Sadji). From
2010 to week 48 of 2014, the country only recorded 551 suspected cholera cases [17–21]. We
hypothesize that the Togo isolates rather represent the descendants of a much larger epidemic
cluster from a neighboring country experiencing severe cholera epidemics, such as the nearby
countries of Ghana and Nigeria. From 2010 to week 48 of 2014, Ghana reported 48,546 sus-
pected cholera cases [17–21]. During that same five-year period, Nigeria signaled a staggering
110,904 suspected cases [17–21]. Isolates from these affected countries would have to be ana-
lyzed to test this hypothesis.
As V. cholerae is autochthonous in the coastal aquatic ecosystem, it has been widely pre-
sumed that cholera epidemics are triggered by environmental factors that promote growth of
local bacterial reservoirs [22]. However, all six of the environmental isolates collected from a
range of countries were genetically unrelated singletons. We acknowledge that additional envi-
ronmental isolates of V. cholerae should be included in the panel to affirm the relationship (or
lack of) between clinical outbreak strains and those found in water bodies. Indeed, to examine
the diversity of environmental strains, efforts should be made to collect further samples. Never-
theless, our preliminary analysis of the environmental samples correlates with two recent re-
views elucidating the environmental determinants of cholera outbreaks in Africa. These
reviews by Rebaudet et al. [5,6] found that at least 76% of cholera cases in Sub-Saharan Africa
occurred in non-coastal regions located over 100 km from the coast. From 2009 to 2011, annu-
al incidence rates of cholera were three times higher in inland Africa compared with the coastal
region. In fact, toxigenic V. cholerae isolates have only been recovered from the environment
during an outbreak, when patient-derived contamination of water sources is expected [5,6].
Our findings are also consistent with the phylogenic assessment of an extensive panel of sev-
enth pandemic V. cholerae isolates. Mutreja et al. [23] have revealed that a specific V. cholerae
El Tor clonal lineage appears to be responsible for the current pandemic. Their study demon-
strated that the seventh pandemic is monophyletic and originated from a single ancestral clone
that has radiated globally in distinct waves [23]. Lineages of the current pandemic appear to
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emerge, diversify and eventually become extinct [23]. Notably, we observed a similar phenome-
non at a smaller scale with the DRC 2009, DRC 2011/2012, Guinea 2012 and Zambia 2012 epi-
demics. As isolates from the African Great Lakes Region were not included in the seventh
pandemic phylogeny, whole-genome sequencing and phylogenic analysis of this panel of Afri-
can strains would provide even further insight into the mechanisms of cholera epidemics in the
region. Together, MLVA and whole-genome sequencing-based phylogeny represent comple-
mentary approaches to better understand epidemic dynamics. MLVA is useful to elucidate the
short-term microevolution of clonal complexes, while sequence-based phylogeny enables the
identification of distant ancestors and related strains at a global level.
Concerning the limitations of the study, our findings would be bolstered by increased isolate
sampling of several years in these and neighboring affected countries. Indeed, we could not ver-
ify that MLVA type #67 isolates found in the DRC persisted in the country throughout the
2010 epidemic, as few isolates were collected in 2010 due to a lack of funding for the epidemio-
logical surveillance and prevention of cholera. Likewise, the analysis of the Togolese epidemics
would benefit from additional isolate sampling in neighboring countries. Finally, although en-
vironmental V. cholerae samples are difficult to isolate, this study would be enhanced by in-
cluding additional isolates found in water bodies located in cholera-endemic areas.
Further studies should address the detailed mechanisms of cholera in the zones where chol-
era appears to persist. If the cholera dilemma in Africa can be narrowed down to a few locales,
secondary affected areas (such as perhaps Togo and Guinea) may be largely protected by tar-
geted interventions in cholera epicenters such as the DRC, Ghana and Nigeria. Therefore, with
a clear understanding of cholera dynamics in the region, public health resources would be most
effectively and efficiently applied.
Overall, our results show that cholera is indeed a regional public health dilemma in Africa.
With varying dynamics in each country, certain strains are able to persist in a given region over
a period of several years and occasionally spread into non-endemic areas or neighboring coun-
tries. Indeed, several elements play a role in cholera epidemics including climate, geography,
economy, hygiene, sanitation, access to potable water and population movement, as addressed
in the corresponding epidemiological reports (concerning the Togo field investigation, please
see S1 Text) [9, 16]. Therefore, public health strategies should be optimized according to the
dynamics and scale of cholera epidemics in each region. These findings also demonstrate the
importance of monitoring the circulation of the bacterium among human populations, which
appear to serve as the principal reservoir of toxigenic V. cholerae. Combined with classical epi-
demiological investigations, MLVA represents a rapid and discriminatory tool to track out-
break evolution at an epidemic and regional level.
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